Dr.Isa Ardahanli is an associate professor at Seyh Edebali University Faculty of Medicine and Department of Cardiology in Turkey. He completed a master's degree in Medicine at Ataturk University in Turkey and a doctorate in cardiology at Bozok University in Turkey. In 2010, he received training in the field of treatment of toxic substances by hemodialysis. He worked as a chief cardiologist at Bilecik Education and Training Hospital Cardiology clinic. Member of Turkish Society of Cardiology (TSC). Member of the Turkish Society of Nephrology (TSN). Member of the association for advanced clinical research (KAD). Member of Ankara Association of Pharmaceutical Sciences (FABAD).
Dr. Isa Ardahanli's research interests are new pharmacological treatment modalities in Heart failure, Medicinal chemistry, and the treatment of other cardiac diseases. His current research focuses on the investigation of SGLT-2 inhibitors with pleiotropic activity for use as an alternative in the treatment of chronic heart failure in humans.